Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.
Clinical trial NCT05181592 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05181592
- Sponsor
- GWT-TUD GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2026-10-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.